Literature DB >> 23687571

Healthcare-Associated Infections at a Children's Cancer Hospital, 1983-2008.

Jonathan A McCullers1, Bonnie F Williams2, Song Wu3, Matthew P Smeltzer3, Bobby G Williams2, Randall T Hayden4, Scott C Howard5, Ching-Hon Pui6, Walter T Hughes7.   

Abstract

BACKGROUND: Little is known about the incidence and etiology of healthcare-associated infections in immunosuppressed children.
METHODS: Data collected prospectively between 1983 and 2008 were used to analyze changes in the rate, types of infection, and infecting organisms over time in patients treated at a children's cancer hospital. Neutropenia was evaluated as a risk factor.
RESULTS: Over the 26-year study period, 1986 healthcare-associated infections were identified during 1653 hospitalizations. The infection rate decreased significantly from 5.6 to 2.0 infections per 100 discharges (P < .01) and from 9.0 to 3.7 infections per 1000 patient-days (P < .01). Bloodstream infections were the most common type of infection (32.7% of all infections). Staphylococci (46.4% of Gram-positive bacteria), Escherichia coli (36.7% of Gram-negative bacteria), and Candida spp. (68.7% of fungi) were the most common pathogens isolated. An absolute neutrophil count (ANC) nadir <100 per mm(3) was significantly associated (P < .0001) with an increased rate of infections compared with higher ANC nadirs.
CONCLUSIONS: Despite a steady expansion in hospital capacity and patient encounters over the last 3 decades, rates of healthcare-associated infections decreased significantly at our hospital. These data suggest that sustained decreases in the rate of healthcare-associated infections in immunosuppressed children are possible. An ANC <100 per mm(3) is a risk factor for healthcare-associated infections in this population.
© The Author 2012. Published by Oxford University Press on behalf of the Pediatric Infectious Diseases Society. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Year:  2012        PMID: 23687571      PMCID: PMC3656547          DOI: 10.1093/jpids/pis034

Source DB:  PubMed          Journal:  J Pediatric Infect Dis Soc        ISSN: 2048-7193            Impact factor:   3.164


  21 in total

1.  2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer.

Authors:  Walter T Hughes; Donald Armstrong; Gerald P Bodey; Eric J Bow; Arthur E Brown; Thierry Calandra; Ronald Feld; Philip A Pizzo; Kenneth V I Rolston; Jerry L Shenep; Lowell S Young
Journal:  Clin Infect Dis       Date:  2002-02-13       Impact factor: 9.079

2.  A history of St Jude Children's Research Hospital.

Authors:  Joseph V Simone
Journal:  Br J Haematol       Date:  2003-02       Impact factor: 6.998

3.  Minimal residual disease-directed therapy for childhood acute myeloid leukaemia: results of the AML02 multicentre trial.

Authors:  Jeffrey E Rubnitz; Hiroto Inaba; Gary Dahl; Raul C Ribeiro; W Paul Bowman; Jeffrey Taub; Stanley Pounds; Bassem I Razzouk; Norman J Lacayo; Xueyuan Cao; Soheil Meshinchi; Barbara Degar; Gladstone Airewele; Susana C Raimondi; Mihaela Onciu; Elaine Coustan-Smith; James R Downing; Wing Leung; Ching-Hon Pui; Dario Campana
Journal:  Lancet Oncol       Date:  2010-05-05       Impact factor: 41.316

4.  Epidemiologic study of 4684 hospital-acquired infections in pediatric patients.

Authors:  E L Ford-Jones; C M Mindorff; J M Langley; U Allen; L Nàvàs; M L Patrick; R Milner; R Gold
Journal:  Pediatr Infect Dis J       Date:  1989-10       Impact factor: 2.129

5.  Bloodstream infections in cancer patients.

Authors:  Walter T Hughes
Journal:  Eur J Cancer       Date:  2005-07       Impact factor: 9.162

6.  CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting.

Authors:  Teresa C Horan; Mary Andrus; Margaret A Dudeck
Journal:  Am J Infect Control       Date:  2008-06       Impact factor: 2.918

7.  Estimating health care-associated infections and deaths in U.S. hospitals, 2002.

Authors:  R Monina Klevens; Jonathan R Edwards; Chesley L Richards; Teresa C Horan; Robert P Gaynes; Daniel A Pollock; Denise M Cardo
Journal:  Public Health Rep       Date:  2007 Mar-Apr       Impact factor: 2.792

Review 8.  Efficacy of oral prophylactic antibiotics in neutropenic afebrile oncology patients: a systematic review of randomised controlled trials.

Authors:  M D van de Wetering; M A de Witte; L C M Kremer; M Offringa; R J P M Scholten; H N Caron
Journal:  Eur J Cancer       Date:  2005-07       Impact factor: 9.162

9.  Brief report: nosocomial infection rates in a cancer treatment center.

Authors:  G V Robinson; B R Tegtmeier; J A Zaia
Journal:  Infect Control       Date:  1984-06

10.  Nosocomial infections in neutropenic cancer patients.

Authors:  P S Carlisle; R Gucalp; P H Wiernik
Journal:  Infect Control Hosp Epidemiol       Date:  1993-06       Impact factor: 3.254

View more
  3 in total

Review 1.  Staphylococcus aureus - antimicrobial resistance and the immunocompromised child.

Authors:  J Chase McNeil
Journal:  Infect Drug Resist       Date:  2014-05-07       Impact factor: 4.003

2.  Levofloxacin Prophylaxis During Induction Therapy for Pediatric Acute Lymphoblastic Leukemia.

Authors:  Joshua Wolf; Li Tang; Patricia M Flynn; Ching-Hon Pui; Aditya H Gaur; Yilun Sun; Hiroto Inaba; Tracy Stewart; Randall T Hayden; Hana Hakim; Sima Jeha
Journal:  Clin Infect Dis       Date:  2017-11-13       Impact factor: 9.079

3.  Clinical Significance of Isolates Known to Be Blood Culture Contaminants in Pediatric Patients.

Authors:  Sejong Chun; Cheol-In Kang; Yae-Jean Kim; Nam Yong Lee
Journal:  Medicina (Kaunas)       Date:  2019-10-17       Impact factor: 2.430

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.